No abstract available
MeSH terms
-
Adalimumab / economics
-
Adalimumab / therapeutic use
-
Biosimilar Pharmaceuticals* / economics
-
Biosimilar Pharmaceuticals* / therapeutic use
-
Drug Costs
-
Europe
-
Humans
-
Infliximab / economics
-
Infliximab / therapeutic use
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Biosimilar Pharmaceuticals
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Adalimumab